Exp/sample | Flow cell # | Run # | # of active pores | Run time (min) | Total reads | Pass reads | Fail reads | Pass/fail rate | Target virus | # of aligned reads | Avg read length [range] (bp) | Avg read error ratea |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Chik1 | 1 | First run | 345 | 138 | 19,452 | 5,139 | 14,313 | 35.9 % | CHIKV | 556 | 455 [126–1477] | 20.6 % (8–49 %) |
Ebola1 | 1 | First run | 105 | 1022 | 13,090 | 1,831 | 11,259 | 16.3 % | EBOV | 41 | 358 [220–672] | 22.0 % (12–43 %) |
HepC1 | 2 | First run | 171 | 122 | 10,305 | 729 | 9,877 | 7.4 % | HCV | 6 | 572 [318–792] | 33.1 % (24–46 %) |
HepC1 | 2 | Reload #1 | 293 | 192 | 26,626 | 2,155 | 25,758 | 8.4Â % | HCV | Â | Â | Â |
HepC1 | 2 | Reload #2 | 256 | 298 | 32,212 | 1,207 | 31,289 | 3.9Â % | HCV | Â | Â | Â |
HepC1 | 2 | Reload #3 | 214 | 156 | 14,805 | 287 | 14,275 | 2.0Â % | HCV | Â | Â | Â |
Ebola2 | 3 | First run | 397 | 79 | 28,651 | 1,537 | 27,114 | 5.7 % | EBOV | 593 | 456 [189–1430] | 22.3 % (8–48 %) |
Ebola2 | 3 | Reload #1 | 426 | 222 | 95,861 | 2,899 | 92,962 | 3.1Â % | EBOV | Â | Â | Â |
Ebola2 | 3 | Reload #2 | 380 | 1091 | 166,524 | 1,539 | 164,985 | 0.9Â % | EBOV | Â | Â | Â |
Ebola2 | 3 | Reload #3 | 200 | 1357 | 44,272 | 34 | 44,238 | 0.1Â % | EBOV | Â | Â | Â |
TOTAL |  |  |  |  | 451,798 | 17,357 | 436,070 | 4.0 % |  |  | 452 [126–1477] | 24.3 % (8–49 %) |